INO
INOVIO PHARMACEUTICALS, INC.
+0.08 (+7.03%)1.23USD1.5M成交股數127M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-10下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | 05-21 | Humeau Laurent | Chief Scientific Officer | F 繳稅扣股 | 2.2K | 1.23 | 3K | 46.8K | SEC |
| 2026-05-20 | 05-21 | Humeau Laurent | Chief Scientific Officer | M 選擇權執行 | 6.0K | – | – | 49.0K | SEC |
| 2026-05-20 | 05-21 | Sumner Michael John | Chief Medical Officer | F 繳稅扣股 | 2.7K | 1.23 | 3K | 42.0K | SEC |
| 2026-05-20 | 05-21 | KIES PETER | CFO | M 選擇權執行 | 8.7K | – | – | 47.5K | SEC |
| 2026-05-20 | 05-21 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 9.4K | – | – | 44.7K | SEC |
| 2026-05-20 | 05-21 | Shea Jacqueline Elizabeth | Chief Executive Officer | M 選擇權執行 | 28.3K | – | – | 123K | SEC |
| 2026-05-20 | 05-21 | KIES PETER | CFO | F 繳稅扣股 | 4.7K | 1.23 | 6K | 42.9K | SEC |
| 2026-05-20 | 05-21 | Shea Jacqueline Elizabeth | Chief Executive Officer | F 繳稅扣股 | 12.3K | 1.23 | 15K | 111K | SEC |
| 2026-05-15 | 05-18 | Humeau Laurent | Chief Scientific Officer | M 選擇權執行 | 4.8K | – | – | 44.7K | SEC |
| 2026-05-15 | 05-18 | Humeau Laurent | Chief Scientific Officer | F 繳稅扣股 | 1.7K | 1.30 | 2K | 43.0K | SEC |
| 2026-05-15 | 05-18 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 2.4K | – | – | 36.0K | SEC |
| 2026-05-15 | 05-18 | KIES PETER | CFO | F 繳稅扣股 | 2.6K | 1.30 | 3K | 38.8K | SEC |
| 2026-05-15 | 05-18 | KIES PETER | CFO | M 選擇權執行 | 4.8K | – | – | 41.4K | SEC |
| 2026-05-15 | 05-18 | Shea Jacqueline Elizabeth | Chief Executive Officer | F 繳稅扣股 | 7.7K | 1.30 | 10K | 95.0K | SEC |
| 2026-05-15 | 05-18 | Sumner Michael John | Chief Medical Officer | F 繳稅扣股 | 680 | 1.30 | 884.00 | 35.3K | SEC |
| 2026-05-15 | 05-18 | Shea Jacqueline Elizabeth | Chief Executive Officer | M 選擇權執行 | 17.7K | – | – | 103K | SEC |
| 2026-03-31 | 04-01 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 4.3K | – | – | 34.8K | SEC |
| 2026-03-31 | 04-01 | Sumner Michael John | Chief Medical Officer | F 繳稅扣股 | 1.2K | 1.74 | 2K | 33.6K | SEC |
| 2026-02-26 | 02-27 | Shea Jacqueline Elizabeth | Chief Executive Officer | M 選擇權執行 | 18.6K | – | – | 78.3K | SEC |
| 2026-02-26 | 02-27 | Shea Jacqueline Elizabeth | Chief Executive Officer | F 繳稅扣股 | 13.7K | 1.79 | 24K | 85.0K | SEC |
| 2026-02-26 | 02-27 | Weiner David B. | Director | M 選擇權執行 | 972 | – | – | 87.6K | SEC |
| 2026-02-26 | 02-27 | Humeau Laurent | Chief Scientific Officer | M 選擇權執行 | 7.4K | – | – | 42.9K | SEC |
| 2026-02-26 | 02-27 | Humeau Laurent | Chief Scientific Officer | F 繳稅扣股 | 2.1K | 1.79 | 4K | 35.6K | SEC |
| 2026-02-26 | 02-27 | KIES PETER | CFO | F 繳稅扣股 | 6.3K | 1.79 | 11K | 36.6K | SEC |
| 2026-02-26 | 02-27 | Humeau Laurent | Chief Scientific Officer | F 繳稅扣股 | 3.0K | 1.79 | 5K | 39.9K | SEC |
| 2026-02-26 | 02-27 | Humeau Laurent | Chief Scientific Officer | M 選擇權執行 | 5.0K | – | – | 37.6K | SEC |
| 2026-02-26 | 02-27 | Shea Jacqueline Elizabeth | Chief Executive Officer | F 繳稅扣股 | 8.1K | 1.79 | 14K | 70.3K | SEC |
| 2026-02-26 | 02-27 | Shea Jacqueline Elizabeth | Chief Executive Officer | M 選擇權執行 | 28.4K | – | – | 98.7K | SEC |
| 2026-02-26 | 02-27 | KIES PETER | CFO | M 選擇權執行 | 10.6K | – | – | 42.9K | SEC |
| 2026-02-26 | 02-27 | KIES PETER | CFO | M 選擇權執行 | 5.0K | – | – | 35.3K | SEC |
| 2026-02-26 | 02-27 | KIES PETER | CFO | F 繳稅扣股 | 3.0K | 1.79 | 5K | 32.3K | SEC |
| 2026-02-26 | 02-27 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 11.6K | – | – | 34.4K | SEC |
| 2026-02-26 | 02-27 | Sumner Michael John | Chief Medical Officer | F 繳稅扣股 | 3.9K | 1.79 | 7K | 30.5K | SEC |
| 2026-02-26 | 02-27 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 5.0K | – | – | 22.9K | SEC |
| 2025-06-30 | 07-01 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 2.9K | – | – | 17.9K | SEC |
| 2025-05-21 | 05-21 | Weiner David B. | Director | M 選擇權執行 | 2.2K | – | – | 86.6K | SEC |
| 2025-05-21 | 05-21 | DANSEY ROGER D | Director | M 選擇權執行 | 2.2K | – | – | 8.9K | SEC |
| 2025-05-21 | 05-21 | Zoth Lota S. | Director | M 選擇權執行 | 2.2K | – | – | 8.7K | SEC |
| 2025-05-21 | 05-21 | Miller Ann Calby | Director | M 選擇權執行 | 2.2K | – | – | 9.9K | SEC |
| 2025-05-21 | 05-21 | Shepard Jay | Director | M 選擇權執行 | 2.2K | – | – | 9.2K | SEC |
| 2025-05-21 | 05-21 | BENITO SIMON X | Director | M 選擇權執行 | 2.2K | – | – | 12.2K | SEC |
| 2025-05-21 | 05-21 | YARNO WENDY L | Director | M 選擇權執行 | 2.2K | – | – | 10.5K | SEC |
| 2025-05-15 | 05-16 | Humeau Laurent | Chief Scientific Officer | M 選擇權執行 | 4.8K | – | – | 34.3K | SEC |
| 2025-05-15 | 05-16 | Shea Jacqueline Elizabeth | Chief Executive Officer | F 繳稅扣股 | 7.7K | 1.95 | 15K | 59.7K | SEC |
| 2025-05-15 | 05-16 | Sumner Michael John | Chief Medical Officer | F 繳稅扣股 | 680 | 1.95 | 1K | 14.9K | SEC |
| 2025-05-15 | 05-16 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 2.4K | – | – | 15.6K | SEC |
| 2025-05-15 | 05-16 | Shea Jacqueline Elizabeth | Chief Executive Officer | M 選擇權執行 | 17.7K | – | – | 67.4K | SEC |
| 2025-05-15 | 05-16 | KIES PETER | CFO | F 繳稅扣股 | 2.6K | 1.95 | 5K | 30.3K | SEC |
| 2025-05-15 | 05-16 | KIES PETER | CFO | M 選擇權執行 | 4.8K | – | – | 32.8K | SEC |
| 2025-05-15 | 05-16 | Humeau Laurent | Chief Scientific Officer | F 繳稅扣股 | 1.7K | 1.95 | 3K | 32.6K | SEC |
| 2025-05-10 | 05-12 | Shea Jacqueline Elizabeth | Chief Executive Officer | F 繳稅扣股 | 2.4K | 1.80 | 4K | 49.7K | SEC |
| 2025-05-10 | 05-12 | Shea Jacqueline Elizabeth | Chief Executive Officer | M 選擇權執行 | 5.5K | – | – | 52.0K | SEC |
| 2025-02-26 | 02-28 | Shea Jacqueline Elizabeth | Chief Executive Officer | F 繳稅扣股 | 9.1K | 1.98 | 18K | 46.5K | SEC |
| 2025-02-26 | 02-28 | Shea Jacqueline Elizabeth | Chief Executive Officer | M 選擇權執行 | 18.6K | – | – | 55.6K | SEC |
| 2025-02-26 | 02-28 | Shea Jacqueline Elizabeth | Chief Executive Officer | F 繳稅扣股 | 2.5K | 1.98 | 5K | 37.0K | SEC |
| 2025-02-26 | 02-28 | Shea Jacqueline Elizabeth | Chief Executive Officer | M 選擇權執行 | 5.9K | – | – | 39.5K | SEC |
| 2025-02-26 | 02-28 | KIES PETER | CFO | F 繳稅扣股 | 3.0K | 1.98 | 6K | 28.1K | SEC |
| 2025-02-26 | 02-28 | KIES PETER | CFO | M 選擇權執行 | 5.0K | – | – | 31.0K | SEC |
| 2025-02-26 | 02-28 | KIES PETER | CFO | F 繳稅扣股 | 2.4K | 1.98 | 5K | 26.0K | SEC |
| 2025-02-26 | 02-28 | KIES PETER | CFO | M 選擇權執行 | 4.0K | – | – | 28.4K | SEC |
| 2025-02-26 | 02-28 | Weiner David B. | Director | M 選擇權執行 | 972 | – | – | 84.5K | SEC |
| 2025-02-26 | 02-28 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 5.0K | – | – | 13.2K | SEC |
| 2025-02-26 | 02-28 | Humeau Laurent | Chief Scientific Officer | F 繳稅扣股 | 1.6K | 1.98 | 3K | 26.6K | SEC |
| 2025-02-26 | 02-28 | Humeau Laurent | Chief Scientific Officer | M 選擇權執行 | 3.9K | – | – | 28.2K | SEC |
| 2025-02-26 | 02-28 | Humeau Laurent | Chief Scientific Officer | M 選擇權執行 | 5.0K | – | – | 31.6K | SEC |
| 2025-02-26 | 02-28 | Weiner David B. | Director | M 選擇權執行 | 972 | – | – | 83.5K | SEC |
| 2025-02-26 | 02-28 | Humeau Laurent | Chief Scientific Officer | F 繳稅扣股 | 2.1K | 1.98 | 4K | 29.6K | SEC |
| 2024-06-30 | 07-01 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 2.9K | – | – | 8.2K | SEC |
| 2024-05-15 | 05-16 | Shepard Jay | Director | M 選擇權執行 | 2.2K | – | – | 7.0K | SEC |
| 2024-05-15 | 05-16 | KIES PETER | CFO | M 選擇權執行 | 4.8K | – | – | 26.9K | SEC |
| 2024-05-15 | 05-16 | Humeau Laurent | Chief Scientific Officer | F 繳稅扣股 | 1.7K | 13.07 | 22K | 24.3K | SEC |
| 2024-05-15 | 05-16 | Humeau Laurent | Chief Scientific Officer | M 選擇權執行 | 4.8K | – | – | 26.0K | SEC |
| 2024-05-15 | 05-16 | Sumner Michael John | Chief Medical Officer | M 選擇權執行 | 2.4K | – | – | 5.3K | SEC |
| 2024-05-15 | 05-16 | Weiner David B. | Director | M 選擇權執行 | 2.2K | – | – | 82.5K | SEC |
| 2024-05-15 | 05-16 | YARNO WENDY L | Director | M 選擇權執行 | 2.2K | – | – | 8.3K | SEC |
| 2024-05-15 | 05-16 | Zoth Lota S. | Director | M 選擇權執行 | 2.2K | – | – | 6.6K | SEC |
| 2024-05-15 | 05-16 | DANSEY ROGER D | Director | M 選擇權執行 | 2.2K | – | – | 6.7K | SEC |
| 2024-05-15 | 05-16 | KIES PETER | CFO | F 繳稅扣股 | 2.6K | 13.07 | 33K | 24.4K | SEC |
| 2024-05-15 | 05-16 | Shea Jacqueline Elizabeth | Chief Executive Officer | F 繳稅扣股 | 7.7K | 13.07 | 101K | 33.6K | SEC |
| 2024-05-15 | 05-16 | Shea Jacqueline Elizabeth | Chief Executive Officer | M 選擇權執行 | 17.7K | – | – | 41.4K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 8.5M | 9.3M | 新進 | 新進 |
| Jupiter Topco LLC | 5.2M | 5.7M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7M | 4.0M | 新進 | 新進 |
| Boxer Capital Management, LLC | 2.8M | 3.1M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 2.1M | 2.4M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 1.4M | 1.5M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.2M | 1.4M | 新進 | 新進 |
| Eversept Partners, LP | 1.0M | 1.1M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 803K | 884K | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 796K | 876K | 新進 | 新進 |
| BlackRock, Inc. | 779K | 857K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 481K | 529K | 新進 | 新進 |
| Caption Management, LLC | 479K | 527K | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 361K | 397K | 新進 | 新進 |
| STATE STREET CORP | 337K | 370K | 新進 | 新進 |
| UBS Group AG | 262K | 289K | 新進 | 新進 |
| Quadrature Capital Ltd | 259K | 285K | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 242K | 266K | 新進 | 新進 |
| NORTHERN TRUST CORP | 174K | 192K | 新進 | 新進 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 173K | 190K | 新進 | 新進 |
| NOMURA HOLDINGS INC | 150K | 165K | 新進 | 新進 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 134K | 147K | 新進 | 新進 |
| GMT Capital Corp | 126K | 139K | 新進 | 新進 |
| JANE STREET GROUP, LLC | 125K | 137K | 新進 | 新進 |
| XTX Topco Ltd | 106K | 116K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 103 +4 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 103 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 32.8M · 31.7% |
| 合計季末市值 | 35.6M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 19.3M |
|---|---|
| 與上期比 | -3.6% |
| 佔流通股數 | 18.62% |
| 日均成交量 | 4.4M |
| 回補天數 | 4.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 19.3M | -3.6% | 18.62% | 4.4M | 4.4 |
| 2026-08-14 | 20.0M | +24.4% | 19.31% | 5.4M | 3.7 |
| 2026-07-31 | 16.0M | +10.1% | 15.52% | 5.1M | 3.1 |
| 2026-07-15 | 14.6M | -3.1% | 14.09% | 1.6M | 9.2 |
| 2026-06-30 | 15.0M | -7.2% | 14.55% | 1.4M | 10.4 |
| 2026-06-15 | 16.2M | -0.4% | 15.67% | 1.5M | 10.8 |
| 2026-05-29 | 16.3M | +1.8% | 15.73% | 2.8M | 5.8 |
| 2026-05-15 | 16.0M | +12.3% | 15.45% | 5.0M | 3.2 |
| 2026-04-30 | 14.2M | +11.5% | 13.77% | 1.5M | 9.8 |
| 2026-04-15 | 12.8M | +29.2% | 12.35% | 4.7M | 2.7 |
| 2026-03-31 | 9.9M | -8.1% | 9.56% | 821K | 12.0 |
| 2026-03-13 | 10.8M | -1.9% | 10.40% | 727K | 14.8 |
| 2026-02-27 | 11.0M | -4.0% | 10.60% | 762K | 14.4 |
| 2026-02-13 | 11.4M | -8.3% | 11.04% | 1.1M | 10.1 |
| 2026-01-30 | 12.5M | +6.5% | 12.04% | 994K | 12.5 |
| 2026-01-15 | 11.7M | +18.5% | 11.31% | 2.0M | 5.9 |
| 2025-12-31 | 9.9M | +4.5% | 9.54% | 2.3M | 4.4 |
| 2025-12-15 | 9.4M | +9.5% | 9.14% | 1.2M | 7.7 |
| 2025-11-28 | 8.6M | +4.5% | 8.35% | 1.0M | 8.6 |
| 2025-11-14 | 8.3M | +0.6% | 7.99% | 1.7M | 4.9 |
| 2025-10-31 | 8.2M | +8.3% | 7.94% | 1.0M | 8.0 |
| 2025-10-15 | 7.6M | -0.6% | 7.33% | 1.0M | 7.5 |
| 2025-09-30 | 7.6M | +1.8% | 7.38% | 932K | 8.2 |
| 2025-09-15 | 7.5M | +13.6% | 7.25% | 2.1M | 3.6 |
| 2025-08-29 | 6.6M | +17.1% | 6.38% | 2.3M | 2.9 |
| 2025-08-15 | 5.6M | +10.5% | 5.45% | 2.2M | 2.6 |